Tenaya Therapeutics is a biopharmaceutical company focused on addressing heart failure through multipronged efforts that target the fundamental cellular pathologies present in diseased cardiac muscle and that leverage cutting-edge research in cardiac development and regeneration.

Register for Details

For more details on financing and valuation for Tenaya Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Tenaya Therapeutics's ticker symbol?

TNYA

What is Tenaya Therapeutics's stock price?

2.48 as of 10/2/23

Learn more about Tenaya Therapeutics

Forge green plus iconForge green minus icon

What is Tenaya Therapeutics funding to date?

Tenaya Therapeutics has raised $142MM to date.
Forge green plus iconForge green minus icon

When was Tenaya Therapeutics founded?

Tenaya Therapeutics was founded in 2016.
Updated on: Jun 12, 2022

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.